PRFX
PRFX
NASDAQ · Pharmaceuticals

Prf Technologies Ltd

$1.47
+0.02 (+1.38%)
As of Jun 24, 5:35 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +713.6% upside
Low Target $8.59
Average Target $11.96
High Target $16.97
Current Price $1.47
Current
$1.47
Target
$11.96
$8.59 $11.96 avg $16.97
Scenario Analysis
Bear Case
$8.59
484.4%
Low target
Base Case
$11.96
+713.6%
Avg target
Bull Case
$16.97
+1,054.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$17.95
-91.8% from high
52-Week Low
$1.28
+14.8% from low
Target vs 52W High
$11.96
-33.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%